
Meeting with Victrex's CEO: Lee & The IC
Shownotes
Alex Newman and Lord Lee of Trafford are back to delve into the investment case for FTSE 250 manufacturer Victrex (VCT), a manufacturer of ultra-high-performance polymers used in applications ranging from airframes to medical implants.
Joining them is the group’s chief executive Dr James Routh, who took over this year after eight years leading AB Dynamics. They dive into Routh’s background, his strategy for Victrex, as well as the opportunities and risks facing the company. The episode also looks at the latest changes to John’s portfolio.
Let us know your thoughts, or if you have any questions or any suggestions for future guests, by emailing [email protected]
Timestamps
01:56 What does Victrex specialise in?
08:37 Victrex’s turnaround strategy
17:53 Why did it cut its dividend?
25:08 New opportunities
38:44 Lord Lee’s portfolio update
Listen to more podcasts from Investors’ Chronicle by clicking here or heading to Apple, Spotify and YouTube
Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.
Investors' Chronicle is a service by the Financial Times.
Hosted on Acast. See acast.com/privacy for more information.